journal article·2025-11-05

A Tailor-Made Biaryl-Stapled Peptide Nanoprodrug with Esterase-Triggered Dual Immunomodulation for Amplified Cancer Therapy

Zherui Jiang, Jianfeng Huang, Yijia He, Licong Peng, Qihang Li, Yuan Tian, Shaobing Zhou

Nano Letters· Volume 25· Issue 44
Publisher page

Abstract

The limited immune response rate of conventional cancer monoimmunotherapy prompts the pursuit of new therapeutic modalities with improved antitumor efficacy. Here, we report a dual-immunomodulatory stapled peptide nanoassembly for amplified immunometabolic cancer therapy. This nanoprodrug platform features a biaryl-stapled proapoptotic peptide motif covalently conjugated to the indoleamine 2,3-dioxygenase (IDO) inhibitor NLG919 via an ester bond, enabling esterase-triggered payload release within the tumors. Upon activation, the stapled peptide potently induces immunogenic cell death (ICD), while NLG919 selectively inhibits IDO, thereby reversing kynurenine-mediated immunosuppression. Notably, the stapled peptide nanoprodrug achieves prolonged local drug exposure by leveraging the enhanced proteolytic stability and cellular association conferred by the biaryl-stapling architecture. In vivo studies demonstrate that this dual-immunomodulatory strategy significantly improves the efficacy of immunotherapy when combined with PD-L1 blockade. This work paves the way to advance the development of stapled peptide-based nanoplatforms as next-generation cancer immunotherapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Peptidase Inhibition and Analysis · Immunotherapy and Immune Responses · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering

Southwest Jiaotong University

Institute of Biomedical Engineering, College of Medicine

Tianfu Jincheng Laboratory

Funding

National Postdoctoral Program for Innovative Talents · China Postdoctoral Science Foundation · Science and Technology Department of Sichuan Province · Chengdu Municipal Science and Technology Program · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Tianfu Jincheng Laboratory Foundation

References (56)

Show source-provided references
1. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
2. 10.1038/nature1067310.1038/nature10673 ↗
3. 10.1038/s41578-023-00617-210.1038/s41578-023-00617-2 ↗
4. 10.1126/science.aar406010.1126/science.aar4060 ↗
5. 10.1002/anie.20171040710.1002/anie.201710407 ↗
6. 10.1056/NEJMra170348110.1056/NEJMra1703481 ↗
7. 10.1038/s41467-021-21047-010.1038/s41467-021-21047-0 ↗
8. 10.1038/s41573-018-0007-y10.1038/s41573-018-0007-y ↗
9. 10.1002/anie.20220979310.1002/anie.202209793 ↗
10. 10.1002/anie.20211051210.1002/anie.202110512 ↗
11. 10.1002/adma.20237017210.1002/adma.202370172 ↗
12. 10.1038/s41568-024-00674-x10.1038/s41568-024-00674-x ↗
13. 10.1002/anie.20230066210.1002/anie.202300662 ↗
14. 10.1038/nri254510.1038/nri2545 ↗
15. 10.1016/j.jconrel.2021.10.02610.1016/j.jconrel.2021.10.026 ↗
16. 10.1002/anie.20180488210.1002/anie.201804882 ↗
17. 10.1016/j.jconrel.2023.10.03210.1016/j.jconrel.2023.10.032 ↗
18. 10.1021/acsnano.9b0604010.1021/acsnano.9b06040 ↗
19. 10.1021/acsnano.0c0070810.1021/acsnano.0c00708 ↗
20. 10.1021/acsami.9b1713710.1021/acsami.9b17137 ↗
21. 10.31635/ccschem.021.20210096410.31635/ccschem.021.202100964 ↗
22. 10.1021/acs.jmedchem.0c0223710.1021/acs.jmedchem.0c02237 ↗
23. 10.1038/cddis.2016.4710.1038/cddis.2016.47 ↗
24. 10.1021/acs.jmedchem.3c0223210.1021/acs.jmedchem.3c02232 ↗
25. 10.1002/advs.20200130810.1002/advs.202001308 ↗
26. 10.1039/C0MD00111B10.1039/C0MD00111B ↗
27. 10.1073/pnas.100271310710.1073/pnas.1002713107 ↗
28. 10.1021/acs.chemrev.0c0053210.1021/acs.chemrev.0c00532 ↗
29. 10.1021/jm401167510.1021/jm4011675 ↗
30. 10.1039/C6SC00106H10.1039/C6SC00106H ↗
31. 10.1021/jacs.7b0979010.1021/jacs.7b09790 ↗
32. 10.1021/jacs.7b0169810.1021/jacs.7b01698 ↗
33. 10.1002/anie.20131024510.1002/anie.201310245 ↗
34. 10.1021/acs.bioconjchem.1c0036610.1021/acs.bioconjchem.1c00366 ↗
35. 10.1002/cbic.20170035210.1002/cbic.201700352 ↗
36. 10.1039/D1CC06595E10.1039/D1CC06595E ↗
37. 10.1021/bm501026e10.1021/bm501026e ↗
38. 10.1021/acs.bioconjchem.9b0073010.1021/acs.bioconjchem.9b00730 ↗
39. 10.1002/anie.20190013510.1002/anie.201900135 ↗
40. 10.1002/adma.20241708910.1002/adma.202417089 ↗
41. 10.1038/s41577-019-0140-910.1038/s41577-019-0140-9 ↗
42. 10.1002/adma.20200724710.1002/adma.202007247 ↗
43. 10.1158/0008-5472.CAN-17-228510.1158/0008-5472.CAN-17-2285 ↗
44. 10.1126/scitranslmed.300063210.1126/scitranslmed.3000632 ↗
45. 10.1021/acs.nanolett.9b0230610.1021/acs.nanolett.9b02306 ↗
46. 10.1021/acsnano.0c0383310.1021/acsnano.0c03833 ↗
47. 10.1038/s41467-022-31579-810.1038/s41467-022-31579-8 ↗
48. 10.1021/jacs.9b1223210.1021/jacs.9b12232 ↗
49. 10.1002/adma.20190721010.1002/adma.201907210 ↗
50. 10.1016/j.biomaterials.2020.12019010.1016/j.biomaterials.2020.120190 ↗
51. 10.1038/s41467-021-27390-610.1038/s41467-021-27390-6 ↗
52. 10.1038/s41467-024-47188-610.1038/s41467-024-47188-6 ↗
53. 10.1021/cb300527510.1021/cb3005275 ↗
54. 10.1038/ncomms162910.1038/ncomms1629 ↗
55. 10.1039/D2NA00601D10.1039/D2NA00601D ↗
56. 10.1126/sciadv.abb872510.1126/sciadv.abb8725 ↗